Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to assess with the PPQ questionnaire the patient preference for Wynzora compared with therapy carried out previously with Enstilar spray foam. Secondary objectives Assess satisfaction with the treatment. Assess adherence to therapy. Evaluate the impact of various clinical and demographic factors on treatment adherence. Evaluate the efficacy of Wynzora cream therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy

NCT06102356

Psoriasis

COMPLETED

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

NCT00842153

Psoriasis

COMPLETED PHASE4

Etanercept With Tacrolimus for Psoriasis

NCT00134394

Psoriasis

COMPLETED PHASE2

Study Evaluating Management of Patients With Moderate and Severe Psoriasis

NCT00894777

Psoriasis

COMPLETED

Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis

NCT06801821

Psoriasis (PsO) Vitiligo Vulgaris Atopic Dermatitis +1 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psoriasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire

PPQ, TTAQ PTCS

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 18 years of age, of either sex;
* Patients diagnosed with mild-to-moderate psoriasis (PASI and BSA \<10) requiring monotherapy topical with Wynzora;
* Patients who have stopped treatment with Enstilar foam for any reason for at least 30 days; and
* Patients whose medical records are accessible and record all demographic parameters, anthropometric and clinical parameters during the treatment period
* Signature of written informed consent;

Exclusion Criteria

* Patients with palmoplantar, inverse, erythrodermic, guttate, and scalp psoriasis.
* Patients who are taking concomitant systemic therapies for psoriasis, such as. cyclosporine, methotrexate, acitretin, phototherapy or biologic therapies.
* Women who are pregnant or planning to become pregnant.
* Patients with disabilities or other motor problems that could complicate self-medication.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No